Skip to content
Search AI Powered

Latest Stories

Sanofi strengthens its digestive health portfolio with launch of Buscobiota

Sanofi, the manufacturer of leading Irritable Bowel Syndrome brand Buscopan and constipation relief range Dulcolax, is entering into the digestive wellbeing space with the launch of a new food supplement, Buscobiota.

Formulated to support digestive health, Buscobiota is a one-a-day capsule that contains five scientifically studied strains of live cultures, along with calcium, which contributes to the normal function of digestive enzymes. The product can be taken as part of a holistic approach to gut health, particularly for anyone looking for ongoing daily support.


The body requires nutrients to function properly and carry out vital roles. In particular, the gut is home to trillions of bacterial cells, the ‘gut microbiome’, which plays a critical role in digestive health. The bacteria in the gut make up a very important ecosystem which, when balanced, helps to maintain healthy digestion and regular bowel movements. Live cultures can support gut flora diversity, but the type of species or strain is very important.

Buscobiota is a source of live cultures comprising of three types of Lactobacillus and two types of Bifidobacterium which come in a one-a-day, vegetable capsule. The capsules are sold in packs of 30 for a month’s supply and do not require refrigeration. Studies on the individuals strains have also shown that the bacteria are able to pass through the stomach and reach the gut alive.

With increasing demand on the NHS, it has never been more important to empower the nation to live well and encourage good gut self-management. It is estimated that over £1.5bn could be saved each year and reinvested into the NHS if more people had the appropriate tools and awareness to take care of their own health.

Silvina Vilas, Marketing Director of UK and Ireland Sanofi Consumer Health Care, comments: “At Sanofi, we encourage people to take a preventative approach to their health and instill a focus on self-care. Through the addition of Buscobiota to our gastrointestinal portfolio, we aim to provide consumers with a broader range of products that support digestive health. By offering shoppers more choice and empowering people to take control of their own wellbeing, we will continue to support our purpose to serve healthier and fuller lives.”

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
WW International logo with bold bankruptcy notice and confident recovery statement

WeightWatchers was founded in 1963

Pic credit: iStock

US diet company WeightWatchers files for bankruptcy

The famed US diet company originally known as WeightWatchers said it has filed for bankruptcy but will continue operations while its $1.15-billion debt is restructured.

The company, now known as WW International, filed for Chapter 11 bankruptcy protection that it said "will eliminate $1.15 billion in debt from the company's balance sheet, and position WeightWatchers for long-term growth and success."

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Empowering women in pharmacy through self-advocacy

Amandeep Doll speaking at the RPS event 'Advocating for Yourself’

Advocate for yourself – Celebrating International Women’s Day

By Amandeep Doll

Advocating for yourself is about knowing your worth and ensuring that your voice is heard in every aspect of your professional journey.

Keep ReadingShow less